Skip to content
Home
Our Platform
Our Focus
Studies
Clinical Trials
Preclinical Studies
OASIS Trial
Care
Dental Care
Spinal Care
Veterinary Care
About Us
About Theradaptive
Our Team
Our Advisory Board
Careers
Latest News
Video Library
Contact Us
Home
Our Platform
Our Focus
Studies
Clinical Trials
Preclinical Studies
OASIS Trial
Care
Dental Care
Spinal Care
Veterinary Care
About Us
About Theradaptive
Our Team
Our Advisory Board
Careers
Latest News
Video Library
Contact Us
Home
Our Platform
Our Focus
Preclinical Studies
About Us
Careers
News
Contact Us
Home
Our Platform
Our Focus
Preclinical Studies
About Us
Careers
News
Contact Us
Latest
News
In the media, on the web, and more...
In the Media 2021
(other years:
2024-2023
|
2022
|
2021
|
2020
|
2019
)
FDA Grants Theradaptive Breakthrough Medical Device Designation
November 19, 2021
read more
War Paint to Bone Paint: MIT Spinout Aims to Transform Regenerative Meds
April 21, 2021
read more
To Mend Difficult Breaks, Try Porous Implants Treated with “Bone Paint”
March 3, 2021
read more
Theradaptive closes seed round bringing total investment to $17.4M to date.
January 19, 2021
read more
One Fourth of Maryland’s Future 20 are Life Science Companies
January 14, 2021
read more
Theradaptive, Inc. Receives $6.2 Million Infusion of Cash from Seed Funding
January 19, 2021
read more
Frederick biotech Theradaptive raises $6.2M as it heads toward clinical trials
read more
January 14, 2021
Governor Hogan announced Maryland’s Future 20, a list of innovative startups. #USAMRDC licensing partner, Theradaptive Inc is among the five life science companies chosen for the list.
January 14, 2021
read more
Search
Our Site
Search
Search